Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    173

Stocks News & Analysis

stocks

Rio Tinto and Glencore go their separate ways

Our view after merger talks end.
stocks

Amazon earnings: Guidance for $200 billion in capital expenditure in 2026 overshadows good results

We think Amazon stock is moderately undervalued.
stocks

Apple earnings: Impressive Q4 lifts stock, but is it a long-term growth play?

We’ve raised our fair value estimate of Apple stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,075.409.500.10%
CAC 408,273.8411.680.14%
DAX 4024,721.46230.400.94%
Dow JONES (US)50,115.671,206.952.47%
FTSE 10010,369.7560.530.59%
HKSE26,559.95325.29-1.21%
NASDAQ23,031.21490.632.18%
Nikkei 22555,699.531,445.852.66%
NZX 50 Index13,398.2345.79-0.34%
S&P 5006,932.30133.901.97%
S&P/ASX 2008,817.206.300.07%
SSE Composite Index4,065.5810.33-0.25%

Market Movers